SCCS Issued Preliminary Opinion on Cannabidiol (CBD) Used in Cosmetic Products

On 19 November 2025, the Scientific Committee on Consumer Safety (SCCS) of the European Union issued preliminary opinion (SCCS/1685/25) open for comments on Cannabidiol (CBD) (CAS No. 13956-29- 1). The deadline for comments is set for 21 January, 2026.

Preliminary Opinion on Cannabidiol (CBD)

In view of all the available data, the SCCS considers CBD safe when used at concentrations up to 0.19% in dermal cosmetic products and oral cosmetic products-whether used alone or together.

The SCCS considers the presence of THC impurities as safe at concentrations up to 20 0.00025% in dermal and oral cosmetic products – whether used alone or together.

This Opinion does not consider cosmetic products that may lead to exposure of the end user's lungs by inhalation.

If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.

Further Information

https://health.ec.europa.eu/document/download/c7b0b685-a9d4-4ccb-8b90-388f59850c0e_en?filename=sccs_o_307.pdf